Skip to main content

Table 6 QALYs gained and cost savings for original scenario of the mass testing intervention (with 95% CI). Negative cost savings indicate net costs

From: Cost-effectiveness of a whole-area testing pilot of asymptomatic SARS-CoV-2 infections with lateral flow devices: a modelling and economic analysis study

Outcome

QALYs

Costs saved (£)

Cases

6 ( 5—7)

-

Hospitalisations

0 ( 0—0)

170,032 ( 113,354 – 255,047)

ICU admissions

0 ( 0—0)

110,989 ( 66,593 – 133,187)

Deaths

102 ( 75—136)

3,480 ( 2,552 – 4,640)

Programme costs

-

-515,688

Total

108 ( 80—143)

-231,188 ( -333,188—-122,814)